If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
682.80    4.20 (0.62%)
Bid:
679.00
Ask:
679.40
Spread: 0.40 (0.059%)
Market Cap: £54.35b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Director/PDMR Shareholding

10 Mar 2025 14:00

RNS Number : 0409A
NatWest Group plc
10 March 2025
 

10 March 2025

NatWest Group plc

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATION

 

1. NatWest Group plc (the Company) announces that conditional restricted share plan awards (RSP) and deferred awards (Deferred Awards) over ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) have been granted on 7 March 2025 under the NatWest Group plc 2024 Employee Share Plan (the Plan) to the PDMRs set out below:

 

Name of PDMR

Position of PDMR

Award

Maximum no. of

Shares eligible to vest

 

Robert Begbie

CEO, NatWest Commercial & Institutional

RSP

278,153

Deferred Award2

50,812

Angela Byrne

Interim CEO, Retail Banking

Deferred Award1

41,094

Emma Crystal

CEO, Coutts and Wealth Businesses

RSP

217,489

Deferred Award2

44,305

Keiran Foad

Group Chief Risk Officer

RSP

326,234

Deferred Award2

57,339

Scott Marcar

Group Chief Information Officer

RSP

326,234

Deferred Award2

65,761

 Katie Murray

Group Chief Financial Officer

RSP

311,583

Deferred Award2

65,375

Paul Thwaite

Group Chief Executive Officer

RSP

451,682

Deferred Award2

97,215

Jen Tippin

Group Chief Operating Officer

RSP

326,234

Deferred Award2

65,701

The prices per Share used on the grant of the above awards were Deferred Awards1 £4.2431, Deferred Awards2 £4.5783 and RSP £3.7933. The prices are discounted to reflect the absence of dividend equivalents during the vesting period.

 

A pre-vest performance assessment will take place for the RSP at the end of three years. Subject to this, the RSP will be eligible to vest between 2028 and 2032. Deferred Awards will be eligible to vest between 2025 and 2030.

 

Malus provisions will apply to each award up until vesting and clawback provisions will apply for a period of seven years from the date of grant. Such period can be extended to ten years in certain circumstances. Vested Shares retained after payment of associated tax liabilities will be subject to a twelve-month retention period. 

2. The Company announces that long term incentive awards (LTI), Deferred Awards and Buy-out Awards over Shares vested on 7 March 2025 to the PDMRs set out below. The awards were granted under the Plan between March 2019 and August 2024. The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR is set out below:

 

Name of PDMR

Position of PDMR

Award

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

 

No. of vested Shares retained

 

Robert Begbie

 

CEO, NatWest Commercial & Institutional

 

LTI

 

149,999

75,113

74,886

Deferred Award

38,942

19,501

19,441

Angela Byrne

Interim CEO, Retail Banking

Deferred Award

15,747

7,413

8,334

Emma Crystal1

CEO, Coutts and Wealth Businesses

Buy-out Award

41,909

19,727

22,182

Keiran Foad1

Group Chief Risk Officer

Buy-out Award

100,196

47,163

53,033

Scott Marcar1

Group Chief Information Officer

Buy-out Award

130,451

61,405

69,046

 

Katie Murray

 

Group Chief Financial Officer

 

LTI

 

326,943

153,895

173,048

 

Deferred Award

 

41,790

19,671

22,119

 

Paul Thwaite

Group Chief Executive Officer

 

LTI

 

130,230

61,301

68,929

Deferred Award

30,123

14,180

15,943

Jen Tippin1

 

 

Group Chief Operating Officer

LTI

144,576

68,053

76,523

 

Deferred Award

97,743

46,009

51,734

Buy-out Award

159,985

75,306

84,679

1. Vested Shares retained after payment of associated tax liabilities will be subject to retention periods which mirror the retention periods applicable to the PDMR's awards granted by their previous employer.

 

The market price used to meet associated tax liabilities was £4.5761.

 

Vested Shares retained after payment of associated tax liabilities will be subject to retention periods of twelve months, unless otherwise indicated in the table above.

 

3. The Company announces that Shares were delivered to PDMRs on 7 March 2025, as set out below. The Shares delivered represent payment of a fixed share allowance for the three-month period ending 31 March 2025 and have been calculated using a share price of £4.7284.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:

 Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

No. of Shares retained

Robert Begbie

CEO, NatWest Commercial & Institutional

19,167

9,598

9,569

Emma Crystal

CEO, Coutts and Wealth Businesses

14,540

6,844

7,696

Keiran Foad

Group Chief Risk Officer

21,810

10,266

11,544

Scott Marcar

Group Chief Information Officer

21,810

10,266

11,544

Katie Murray

Group Chief Financial Officer

41,661

19,610

22,051

Paul Thwaite

Group Chief Executive Officer

61,103

28,761

32,342

Jen Tippin

Group Chief Operating Officer

21,810

10,266

11,544

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was £4.5761. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs and will be released in instalments over a five year period.

All of the above transactions took place on the London Stock Exchange (XLON).

 

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:

NatWest Group Investor RelationsClaire KaneDirector of Investor Relations+44 20 7672 1758

 

NatWest Group Media Relations 

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFIFESEISEFD
Date   Source Headline
21st Feb 20254:50 pmRNSPublication of Final Terms
21st Feb 202510:29 amRNSNotice of Redemption
14th Feb 20254:05 pmRNSPublication of Suppl.Prospcts
14th Feb 20257:00 amRNSHolding(s) in Company - HMT
14th Feb 20257:00 amRNSNatWest Group plc - Annual Report
14th Feb 20257:00 amRNSNatWest Group plc 2024 Annual Results
31st Jan 20253:33 pmRNSTotal Voting Rights
28th Jan 202510:30 amRNSHolding(s) in Company – HMT shareholding
14th Jan 202510:30 amRNSHolding(s) in Company - HMT shareholding
3rd Jan 20252:00 pmRNSDirector/PDMR Shareholding
31st Dec 20241:06 pmRNSTotal Voting Rights
13th Dec 202411:15 amRNSAppointment of Chief Governance Officer
13th Dec 202410:30 amRNSHolding(s) in Company - HMT
13th Dec 20249:00 amRNSDirectorate Change
6th Dec 20241:47 pmRNSPublication of Prospectus
29th Nov 202412:44 pmRNSTotal Voting Rights
26th Nov 20242:00 pmRNSDirector/PDMR Shareholding
22nd Nov 202410:30 amRNSHolding(s) in Company – HMT shareholding
21st Nov 202410:10 amRNSHolding(s) in Company Capital Group Companies Inc.
18th Nov 20244:24 pmRNSDividend Declaration
18th Nov 20243:00 pmRNSDirector/PDMR Shareholding
15th Nov 20249:41 amRNSNatWest Group plc Filing of Registration Statement
13th Nov 20241:36 pmRNSHolding(s) in Company - HMT Shareholding
13th Nov 20241:11 pmRNSTotal Voting Rights
12th Nov 20242:00 pmRNSDirector/PDMR Shareholding
12th Nov 20247:00 amRNSQ3 2024 Pillar 3
11th Nov 20247:01 amRNSOff-Market Purchase of Ordinary Shares from HMT
11th Nov 20247:00 amRNSDisposal of Shares in NatWest Group plc for £1bn
8th Nov 20242:00 pmRNSDirector/PDMR Shareholding
6th Nov 20241:18 pmRNSNotice of Redemption
31st Oct 20241:02 pmRNSTotal Voting Rights
31st Oct 202410:30 amRNSHolding(s) in Company -HMT
25th Oct 20243:58 pmRNSPublication of Supplementary Prospectus
25th Oct 20247:00 amRNSNWG plc Q3 Results 2024
9th Oct 202410:30 amRNSHolding(s) in Company -HMT
2nd Oct 20244:00 pmRNSDirector/PDMR Shareholding
2nd Oct 202410:57 amRNSBlock Listing Six Monthly Return
30th Sep 20241:07 pmRNSTotal Voting Rights
27th Sep 202412:30 pmRNSDirector Declaration
26th Sep 20241:47 pmRNSNotice of Redemption
24th Sep 20248:00 amRNSBank of America Financials CEO Conference
23rd Sep 202410:30 amRNSHolding(s) in Company - HMT
17th Sep 20244:00 pmRNSDirector/PDMR Shareholding
13th Sep 20244:57 pmRNSPublication of Final Terms
11th Sep 20249:30 amRNSDirector Declaration
10th Sep 20246:02 pmRNSPublication of Final Terms
10th Sep 20243:00 pmRNSDirector/PDMR Shareholding
10th Sep 202412:00 pmRNSBarclays Global Financial Services Conference
30th Aug 202411:31 amRNSTotal Voting Rights
30th Aug 202410:30 amRNSHolding(s) in Company - HMT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.